Features
Get A Demo
Plans
Sign Up
Login
All Federal Contract Awards
Help
Definitive Contract HHSO100201500034C
Award Date
9/29/15
Potential Completion Date
9/30/18
Potential Value
$14M
Overview
🤔 AI Insights
Buyer Personas
Industry Personas
Buyer Personas In this Market
5
Activity
Transactions
1
Subawards
Opportunity Stack
1
Federal Agency
Office of the Assistant Secretary for Preparedness and Response
Awardee
Vaxart Biosciences Inc.
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
PSC Category
AN13 - Health R&D Services; Health Care Services; Experimental Development
Federal Contract Vehicle
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Description
Update #1
Update #2
Update #3
Posted 9/29/15, 12:00 AM
Name
Description
Solicitation Number
Federal Agency
Type
Posted Date
(Click to sort descending)
Medical Research
Added: Jul 16, 2013 11:39 am BARDA encourages the advanced research, development and acquisition of medical countermeasures such as vaccines, therapeutics, and diagnostics, as well as innovative approaches to meet the threat of CBRN agents in support of the preparedness mission and priorities of the HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) articulated in the 2012 PHEMCE Implementation Plan for CBRN Threats. The Implementation Plan is located on the ASPR website: https://www.medicalcountermeasures.gov/media/13962/2012-phemce-implementation-plan.pdf The Pandemic and All Hazard Preparedness Act Pub. L. No. 109-417, 42 U.S.C. § 241 et seq. (PAHPA; http://www.gpo.gov/fdsys/pkg/PLAW-109publ417/pdf/PLAW-109publ417.pdf) and The Pandemic and All Hazard Preparedness Reauthorization Act Pub. L. No. 113-5, (PAHPRA: http://www.gpo.gov/fdsys/pkg/PLAW-113publ5/pdf/PLAW-113publ5.pdf) authorizes BARDA to (i) conduct ongoing searches for, and support calls for, potential qualified countermeasures and qualified pandemic or epidemic products; (ii) direct and coordinate the countermeasure and product advanced research and development activities of the Department of Health and Human Services; (iii) establish strategic initiatives to accelerate countermeasure and product advanced research and development (which may include advanced research and development for purposes of fulfilling requirements under the Federal Food, Drug, and Cosmetic Act or section 351 of this Act) and innovation in such areas as the Secretary may identify as priority unmet need areas; and (iv) award contracts, grants, cooperative agreements, and enter into other transactions, for countermeasure and product advanced research and development. Areas of Interest:The purpose of this BAA is to solicit proposals that focus on one or more of the following areas of interest as listed here and further described in Part I.Research Areas of Interest:1. Vaccines 2. Antitoxins and Therapeutics3. Antimicrobial Drugs4. Radiological/Nuclear Threat Medical Countermeasures5. Chemical Threat Medical Countermeasures6. Clinical Diagnostics ToolsBARDA anticipates that research and development activities awarded from this Broad Agency Announcement (BAA) will serve to advance the knowledge and scientific understanding of candidates' countermeasures for CBRN threats toward eventual FDA approval and their inclusion in the Strategic National Stockpile (SNS).The Government intends to have a full & open competition for this requirement in the form of a BAA. This synopsis is not a BAA; a BAA itself is anticipated to be posted on or about July 31, 2013. The Government expects to make 1 or more awards, subject to the availability of funds. The open period of the BAA will be specified in the BAA itself.Contact Information:Comments to this announcement, referencing synopsis BAA- 13-100-SOL-00013 may be submitted to the following email address: CBRN-BAA-13@hhs.govContracting Office Address:Department of Health & Human Services (DHHS)Office of the Assistant Secretary for Preparedness & Response (ASPR) Acquisition Management Contracts & Grants (AMCG)330 Independence Ave., S.W., Room G-640Washington, D.C. 20201
BAA-13-100-SOL-00013
Department of Health and Human Services Immediate Office of the Secretary
Award Notice 1/1
7/16/13, 11:39 AM
Mod #
Description
Reason For Modification
Federal Obligation
(Click to sort descending)
Date
(Click to sort ascending)
3
VAXART-ADVANCED DEVELOPMENT OF A ROOM TEMPERATURE STABLE, ORAL RECOMBINANT INFLUENZA VACCINE
Supplemental Agreement for work within scope
$0
6/28/18